Feedback

Persistent hiccups due to aripiprazole: a case report and review of the literature

Affiliation
Department of Psychosomatics ,Sichuan Provincial Center for Mental Health ,Sichuan Provincial People’s Hospital, School of Medicine ,University of Electronic Science and Technology of China ,Chengdu ,China
Zhang, Yaoyin;
Affiliation
Key Laboratory of Psychosomatic Medicine ,Chinese Academy of Medical Sciences ,Chengdu ,China
Chen, Wei;
Affiliation
Key Laboratory of Psychosomatic Medicine ,Chinese Academy of Medical Sciences ,Chengdu ,China
Chen, Junming;
Affiliation
Key Laboratory of Psychosomatic Medicine ,Chinese Academy of Medical Sciences ,Chengdu ,China
Li, Mingmei;
Affiliation
Department of Psychosomatics ,Sichuan Provincial Center for Mental Health ,Sichuan Provincial People’s Hospital, School of Medicine ,University of Electronic Science and Technology of China ,Chengdu ,China
Huang, Yulan;
Affiliation
Department of Psychosomatics ,Sichuan Provincial Center for Mental Health ,Sichuan Provincial People’s Hospital, School of Medicine ,University of Electronic Science and Technology of China ,Chengdu ,China
Min, Wenjiao

Introduction: Aripiprazole, a commonly prescribed antipsychotic, has been rarely associated with the onset of hiccups. This study aims to elucidate the prevalence, risk factors, and management of aripiprazole-induced hiccups. Methods: We report a case of aripiprazole-induced hiccups in a 32-year-old male diagnosed with Somatic Symptom Disorder per DSM-5 criteria.A comprehensive literature review was conducted, identifying 29 case reports of aripiprazole-induced hiccups. Patient demographics, dosage, onset and duration of hiccups, and management strategies were analyzed. Results: Aripiprazole-induced hiccups predominantly affected adolescents and middle-aged male patients (86.7%). The majority of hiccups developed within 1–2 days post-prescription (90.9%) and resolved within 1–4 days after discontinuation of aripiprazole. Discontinuation of aripiprazole was the most effective management strategy (51.7%). Co-administration with benzodiazepines was identified as a significant risk factor. Discussion: The findings suggest that clinicians should be vigilant for the onset of hiccups during the early stages of aripiprazole treatment, especially in male patients and those co-administered with benzodiazepines. Conclusion: Clinicians should be vigilant for hiccups during early aripiprazole treatment. Considering personality and psychological factors is crucial in managing hiccups in psychiatric patients.

Cite

Citation style:
Could not load citation form.

Access Statistic

Total:
Downloads:
Abtractviews:
Last 12 Month:
Downloads:
Abtractviews:

Rights

License Holder: Copyright © 2024 Zhang, Chen, Chen, Li, Huang and Min.

Use and reproduction: